Part-Time
Radiologic Technologist
Tenet Healthcare
10,001+ employees
Operates hospitals and clinics; revenue cycle
No salary listed
Detroit, MI, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to Tenet Healthcare
See people who can refer or advise you
- Registration by the American Registry of Radiologic Technologists in Radiography (R).
- Have or successfully complete American Heart Association Basic Life Support—Healthcare Provider training by the end of the orientation period.
- Demonstrate analytical and clinical skills to determine the most age-appropriate method of providing requested radiographs based on patients’ physical abilities and limitations.
- Demonstrate interpersonal and communication skills to effectively deal with and instruct patients under physical or emotional stress, comprehend and follow physicians’ verbal and written requests and prescriptions, and work effectively in a culturally diverse environment.
- Have technical knowledge to operate specialized equipment and computers.
- Work productively and effectively within a complex environment while handling multiple and changing priorities.
- Have the physical stamina for frequent walking, standing, lifting, and positioning of patients, including the ability to stand, bend, push, pull, reach, and lift to provide patient care.
- Have manual dexterity and visual acuity to operate and use x-ray equipment and supplies to produce radiographs of acceptable diagnostic quality.
- Verify patient identity and review the medical record for the appropriateness of the examination or procedure.
- Interview patients to obtain, verify, or update medical history and assess risk factors such as medications, pregnancy, and psychological indicators.
- Explain procedures to patients, including side effects of pharmaceuticals administered, risks, benefits, alternatives, and follow-up.
- Set up equipment and acquire appropriate images according to the script.
- Review images, make initial observations, document exceptions from established protocols, and communicate data to the radiologist.
- Recognize and respond to medical emergencies as appropriate.
- Provide physician-prescribed post-care instructions to patients.
- Participate in radiology practice process-improvement activities, including quality of care, patient flow, reject-repeat analysis, and patient satisfaction.
- Provide imaging education to residents, student technologists, and new employees.
- Take call or standby shifts as required by the department.
Tenet Healthcare operates a large network of hospitals and outpatient facilities across the United States, including 65 hospitals and about 500 other centers such as surgical hospitals, urgent care sites, and imaging centers. It also owns Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients, helping them manage billing and payments and improve patient outcomes. The company earns revenue mainly from patient services and from Conifer’s administrative and financial services. Its goal is to deliver the right care, in the right place, at the right time, while improving patient outcomes and operational efficiency and serving as a trusted employer and partner.
Company Size
10,001+
Company Stage
IPO
Headquarters
Dallas, Texas
Founded
1967
Get referred to Tenet Healthcare
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 adjusted EPS reached $6.12, crushing consensus and lifting guidance July 23.
- Management raised 2026 EBITDA outlook by $295 million and free cash flow by $225 million.
- USPI M&A spending now exceeds $300 million in 2026, expanding higher-margin ambulatory volume.
What critics are saying
- Tenet still faces the Illinois no-poach merits case after June 10, 2026 class denial.
- A single bad federal reimbursement rule can compress hospital margins and erase 2026 guidance.
- Debt-funded buybacks amplify leverage; execution misses turn the stock into a deleveraging story.
What makes Tenet Healthcare unique
- USPI owns 538 ASCs and 26 surgical hospitals across 37 states, scaling outpatient surgery.
- Tenet’s Q2 2026 EBITDA margin hit 23.2%, led by higher-acuity procedures and strict costs.
- Conifer exit economics from CommonSpirit delivered $1.9 billion, boosting cash and focus.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Mental Health Support
Paid Sick Leave
Paid Holidays
Paid Vacation
Health Insurance
Flexible Work Hours
Company News
Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.
Tenet Healthcare (NYSE: THC)'s stock climbs 30.1% year-to-date to $259.45 amid turnaround efforts. 12 August 2026 11:30 AM PDT Summarize with AI You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to its research reports, in-depth technical and fundamental research. Learn more Tenet Healthcare's stock has climbed to $259.45, reflecting a substantial 30.1% gain year-to-date. This recovery signals successful turnaround strategies, making the company an appealing prospect for investors looking for growth in the healthcare sector. Key Highlights * Tenet Healthcare Corp (NYSE: THC). * Tenet Healthcare's recent performance illustrates a successful recovery strategy. * Investors are taking note of Tenet Healthcare's significant year-to-date gain and the implications for its Long-term Growth prospects. Tenet Healthcare Corp (NYSE: THC). has seen its stock price stabilize at $259.45, marking a significant 30.1% appreciation this year as the company pushes its growth initiatives. Investors are encouraged by this upward trend after the stock had fluctuated within a 52-week range of $157.58 to $265.32. With a market cap of $20.9 billion, Tenet demonstrates resilience, capturing investor interest amid rising operational efficiency and strategic market repositioning. The healthcare provider's ongoing turnaround efforts appear to resonate well with the market. What Happened Tenet Healthcare's recent performance illustrates a successful recovery strategy. The company reported strong operational efficiency and a noticeable improvement in its service delivery model. The stock has appreciated 33.2% over the last month, indicating heightened investor confidence in the healthcare provider's trajectory. This timely recovery aligns with a broader trend of increasing acceptance of elective procedures, which Tenet capitalizes on through its extensive network of hospitals and ambulatory care centers. As a result, its stock performance stands out in a notoriously volatile healthcare sector, making it a focal point for investors. Implications Investors are taking note of Tenet Healthcare's significant year-to-date gain and the implications for its long-term growth prospects. Tenet's strategic initiatives, including its investments in free-standing emergency departments and outpatient facilities, position the company favorably against sector peers. The operational improvements and enhanced service offerings may drive stronger Revenue growth, important for maintaining this upward momentum. Comparatively, Tenet's closest competitors, EHC and UHS, have shown less impressive stock movements, which could suggest a competitive edge for Tenet. The company's continued focus on operational excellence could elevate investor sentiment further. What's Next Looking ahead, Tenet Healthcare is expected to face challenges as it strives to sustain its growth momentum. The upcoming quarterly Earnings report will be key, providing insights into how effectively the company can Capitalize on recent gains. Analysts will scrutinize metrics related to patient volumes, service mix, and revenue generation strategies, all of which play a critical role in the company's financial health. As the company navigates potential external challenges like regulatory pressures and market competition, its performance in upcoming reports will be important to maintaining investor confidence. Peers Moving on This News * Encompass Health Corp (NYSE: EHC) little changed * Universal Health Services Inc (NYSE: UHS) down 0.3% FAQs. Q: How has Tenet Healthcare's stock performed recently? A: Tenet Healthcare's shares have risen to $259.45, reflecting a strong 30.1% increase year-to-date, showcasing effective turnaround strategies that attract investors seeking growth. Q: What does Tenet's recent share performance indicate for future growth? A: Tenet's 33.2% increase over the past month suggests positive sentiment surrounding its operational efficiency and service offerings, positioning the company well against competitors in the healthcare market. Q: What are the key factors impacting Tenet Healthcare's stock valuation? A: Key factors include operational improvements, patient volume trends, and strategic investments in outpatient facilities, which significantly influence revenue generation and overall stock performance. Download Free Report - Explore 3 Stock Ideas & Industry Insights Unlock 3 stock ideas and key industry insights in its free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice. All investments involve risk - consider independent advice before making any investment decisions. Disclaimer:
Karmanos files lawsuit against DMC amid rising costs, service threats. The services include laboratory operations, operating room access, scheduling, IT integration, and dietary services. Keep Watching DETROIT - Karmanos Cancer Hospital has filed a lawsuit against Detroit Medical Center and its parent company, Tenet Healthcare, alleging the for-profit health system threatened to cut critical services - a move Karmanos says could jeopardize care for thousands of cancer patients. "We did not arrive at this conclusion or this action lightly," said Brian Gamble, president and CEO of Karmanos Cancer Hospital. The services include laboratory operations, operating room access, scheduling, IT integration and dietary services. "We took this action as a preemptive action to preserve and protect our patients," Gamble said. Background: Karmanos, DMC separate but remain tied. The dispute has roots in a 2005 agreement signed when Karmanos separated from DMC and became Michigan's only independent, freestanding cancer hospital. Under that agreement, Karmanos leases space on DMC's downtown Detroit campus and is required to purchase certain services through DMC. Karmanos says the relationship has grown increasingly strained - citing rising costs and declining service quality. "We are lacking transparency, and we are not satisfied with the solutions and the service levels we are getting," Gamble said. From $28M to $82M: Costs at the center of the dispute. At the heart of the lawsuit is a dramatic increase in service fees. According to the filing, Tenet was charging Karmanos approximately $28 million annually for services. Karmanos alleges Tenet is now seeking $82 million. Karmanos also claims that although it accounts for only 25-30% of operating room utilization, DMC allocates approximately 75% of related costs to the center. The lawsuit states multiple requests for an explanation have gone unanswered. What this means for patients. For now, services have not been disrupted as a judge weighs both sides of the dispute. "Despite our contractual disagreements with Tenet and DMC, there will be no disruption to patient care," Gamble said. Karmanos is one of fewer than 60 National Cancer Institute-designated Comprehensive Cancer Centers in the country and the only one in metro Detroit. The center treated nearly 16,000 new cases in fiscal year 2025 - the most in its history. The lawsuit argues that financial resources that could support enhanced patient care have instead been directed toward payments to DMC, and that DMC has repeatedly blocked Karmanos' efforts to expand and build new facilities. "Bottom line - we're fighting for the future of cancer care in Detroit and our region," Gamble said. "This is about protecting patients, supporting our teams and ensuring Karmanos can continue to grow to improve the quality of service provided and invest and serve the community for generations to come." DMC and Tenet Healthcare have not yet issued a public statement regarding the allegations at the time of this report. "For more than 100 years, the Detroit Medical Center has been this city's healthcare safety net. Thousands of patients are being seen and treated on our campus every day. Karmanos is owned by McLaren Health Care, headquartered in Grand Blanc, and has no other presence in our city, preferring to center their broader healthcare services in wealthier suburbs of Michigan while relying on the DMC to subsidize its operations locally. Karmanos was built here, on DMC's campus, with DMC, for Detroit's patients. DMC supplies to Karmanos what a cancer hospital cannot run without: laboratory, medical records, and operating room services among others. McLaren made a long term commitment with Karmanos in Detroit and now files a frivolous lawsuit as a disguised attempt to renege on their commitments on the DMC campus. For more than a year, McLaren decided on its own what to pay for the support services it uses every day and paid a fraction of the cost. McLaren, as one of the wealthiest hospital systems in America that also owns an insurance company spent over a year asking a Detroit safety-net hospital to subsidize it. We absorbed the loss rather than let a payment dispute reach a single bedside. When finally asked to pay fair market value, McLaren sued, skipping the private mediation its own agreements require. That was a choice about publicity, and not about principle. DMC honored its agreements. To this day, despite subsidizing the cost of these services for Karmanos, all necessary care remains available from the DMC. We expect McLaren to honor its own commitments. We reject the allegations and will answer them in court. We will not be taken advantage of. Not when the people of Detroit are the ones who pay for it. Detroit Medical Center
Tenet Healthcare stock surges after blockbuster Q2 beat. TIM BOHEN - UPDATED JUL. 25, 2026, 8:37 AM ET Tenet Healthcare Corporation stocks have been trading up by 17.17 percent, driven mainly by strong earnings and upbeat guidance. What traders need to know. * Q2 2026 adjusted EPS came in at $6.12 versus $4.26 consensus on $5.63B revenue, powered by strong same-store growth, tight cost control, and higher-acuity services. * Management lifted 2026 guidance to adjusted EPS of $20.30-$21.69 and revenue of $21.9B-$22.5B, with about $295M more EBITDA and $225M more free cash flow at the midpoint. * Share repurchase capacity increased by $2B after $1.04B bought back last quarter, leaving $2.13B available and targeting roughly a 6% reduction in share count at current prices. * The stock ripped more than 16-17% after the earnings release and guidance hike, strongly separating itself from a mostly flat healthcare tape. * Major banks including BofA, Barclays, Wells Fargo, UBS, and Guggenheim all stay positive on THC, with targets clustered roughly in the $231-$290 range. Weekly Update Jul 20 - Jul 24, 2026: On Saturday, July 25, 2026 Tenet Healthcare Corporation stock [NYSE: THC] is trending up by 17.17%! Discover the key drivers behind this movement as well as its expert analysis in the detailed breakdown below. Healthcare industry expert: Analyst sentiment - positive Tenet Healthcare (THC) is operating as a top-tier acute-care and ambulatory consolidator with sector-leading profitability: EBIT margin 18.6%, EBITDA margin 22.8%, and consolidated net margin 7.9% on $21.3B revenue, all above typical hospital peers. Returns on equity (38-49%) and capital (10-25%) are exceptional, powered by strong asset turnover and mix shift to higher-acuity and ASC volumes. Leverage is elevated (total debt/equity 2.7x; LT debt/cap ~73%) but comfortably serviced (interest coverage 5.9x) and supported by $1.46B quarterly FCF, modest capex, and aggressive buybacks at a single-digit P/E (~9x) and 0.7x sales. The stock's weekly tape shows a powerful breakout and follow-through: from ~195 to a spike high near 233, closing at 233.2, confirming a vertical expansion in range with clear institutional demand. Intraday 5-minute candles post-earnings show repeated high-volume buying above 220 and shallow pullbacks, indicating strong dip support rather than distribution. Dominant trend is firmly bullish. A key actionable level is $220: use it as primary support and stop zone for swing longs, with fresh entries on low-volume pullbacks toward 225-228 targeting continuation above recent highs. Fundamentals, revisions, and positioning place Tenet ahead of both the Healthcare sector and Healthcare Providers & Services peers on growth, margins, and FCF conversion. Q2 results massively beat expectations, guidance for 2026 EPS and EBITDA moved materially above Street, and multiple banks raised targets into the $270-290 range as shares jumped >15%. Expanded $2B buyback plus $2.13B remaining capacity adds structural support. I see upside toward $275-285 over 12 months, with key support at $220 and interim resistance near $250. Quick financial overview. Tenet Healthcare Corporation (THC) just printed the kind of quarter that resets expectations. Q2 2026 adjusted EPS of $6.12 not only smashed the $4.26 consensus, it also marked a sharp jump from last year's $4.02. Revenue of $5.63B beat estimates and was backed by higher same-facility revenue and better hospital margins, not just accounting noise. For traders, that matters: strong price and volume in the business usually supports strong price and volume in the stock. The guidance move is just as important. THC now sees 2026 adjusted EPS at $20.30-$21.69 and revenue at $21.9B-$22.5B, with about $295M more adjusted EBITDA and $225M more free cash flow at the midpoint. Key ratios back up this earnings power: EBIT margin sits around 18.6%, EBITDA margin roughly 22.8%, and return on equity is very high near 48.5%. The balance sheet is still leveraged with total debt-to-equity at 2.74, but interest coverage of 5.9 and free cash flow of about $1.46B for the recent quarter help support that load. On valuation, THC trades around a 9.2 P/E and about 0.7 times sales, with price-to-free-cash-flow near 2.5, which is low for a name delivering this type of growth. The chart confirms that traders are re-rating the stock. Weekly data show a breakout from the high-$190s into the low-$230s, with a huge expansion in the range once earnings hit: a move from roughly $199 to a spike near $233-$235 in just days, and an intraday high around $246 on the post-earnings session before closing near $233. That kind of wide intraday bar after a gap up usually signals heavy participation and sets up a new trading range for the coming weeks. Conclusion. This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Its coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, StocksToTrade, Inc. break down the events that can spark significant price action. Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead. Once your watchlist is set, take the next step and trade with confidence using StocksToTrade's robust platform. Don't miss out - grab your 14-day trial for just $7 and experience the edge you need to thrive in today's fast-paced markets. 2x opportunities. Every Monday. Every week on Monday morning... I've been targeting gains up to 149% before lunch. Yes - 2x opportunities. Every Monday. I call it the Money Monday trade... And if you get it right, it could set you up for the whole week!
Tenet Healthcare shares surged 14.6% in premarket trading on Friday after the Dallas-based hospital operator delivered stronger-than-expected second-quarter results and raised its full-year outlook. The company reported earnings of $6.12 per share, well above the $4.26 consensus estimate. Revenue reached $5.63 billion, exceeding expectations of $5.43 billion. Tenet also substantially increased its 2026 guidance, now expecting earnings per share between $20.30 and $21.69, ahead of the previous consensus of $17.81. Revenue guidance was lifted to between $21.9 billion and $22.5 billion. The results come as investors have grown cautious toward hospital operators. Earlier this earnings season, HCA Healthcare lowered its full-year profit outlook after reporting pressure from unfavourable payer mix.